Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 11865148
Methods of delivering transgenes to the eye
granted -
US 11865140
Restimulation of cryopreserved tumor infiltrating lymphocytes
granted -
US 11865288
Devices for applying a topical treatment
granted -
US 11865179
Progesterone formulations having a desirable PK profile
granted -
US 11866710
Transmembrane protease, serine 6 (TMPRSS6) iRNA compositions and methods of use thereof
granted -
US 11866503
Methods for treating inflammatory conditions of the airway or lungs by administering antagonist monoclonal antibodies to interleukin-33 and interleukin-4 receptor
granted -
US 11865157
Compositions and methods of targeting cancer stem cells
granted -
US 11866446
Inhibitors of APOL1 and methods of using same
granted -
US 11865186
Gene therapy treatment of atrial fibrillation
granted -
US 11865111
Antiviral drugs targeting the N-terminal domain (NTD) of the coronavirus spike receptor binding domain (RBD)
granted -
US 11865117
Pharmaceutical compositions comprising meloxicam
granted -
US 11866727
Materials and methods for treatment of glycogen storage disease type 1A
granted -
US 11866502
Anti-FGFR2 antibodies and methods of use thereof
granted -
US 11866742
Fusion proteins comprising enzyme replacement therapy enzymes
granted -
US 11867695
Compositions and methods for detecting protease activity in biological systems
granted -
US 11866442
Bifunctional compounds for degrading BTK via ubiquitin proteosome pathway
granted -
US 11866488
Compositions comprising an anti-metallothionein antibody and a pancreatic cell targeting moiety
granted -
US 11866444
Oxabicycloheptane prodrugs
granted -
US 11866743
Pharmaceutical formulations, methods for treating chemical warfare agent exposure, and modified biomolecules
granted -
US 11865172
Materials and methods for respiratory disease control in canines
granted -
US 11866515
Hemiasterlin derivatives for conjugation and therapy
granted -
US 11865166
Nucleic acid encoding optimized immunogenic peptide that targets follicle stimulating hormone receptor
granted -
US 11866407
Compositions and methods for inhibiting Mpro and PLpro protease activity and for preventing and treating SARS-CoV-2 infection
granted -
US 11866450
Modulators of Cystic Fibrosis Transmembrane Conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulators
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.